cell chronic lymphocytic leukemia Defective T cell-mediated, isotype-specific immunoglobulin regulation in B

[1]  K. Ishizaka,et al.  IgD-binding factors from mouse T lymphocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[2]  N. Noro,et al.  Murine IgA binding factors (IgA-BF) suppressing IgA production: characterization and target specificity of IgA-BF. , 1986, Journal of immunology.

[3]  R. T. Perri.  Impaired expression of cell surface receptors for B cell growth factor by chronic lymphocytic leukemia B cells. , 1986, Blood.

[4]  E. Ebert,et al.  Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety. , 1986, Blood.

[5]  K. Foon,et al.  Chronic lymphocytic leukemia. Recent advances in biology and treatment. , 1985, Annals of internal medicine.

[6]  J. Mcghee,et al.  Isotype-specific immunoregulation. IgA-binding factors produced by Fc alpha receptor-positive T cell hybridomas regulate IgA responses , 1985, The Journal of experimental medicine.

[7]  R. Hoover,et al.  T cells with FC receptors in myeloma; suppression of growth and secretion of MOPC-315 by T alpha cells. , 1985, Journal of immunology.

[8]  J. Banchereau,et al.  Suppression of polyclonal human B cell activation by IgG binding factors: interference with the maturation of Ig-containing cells into Ig-secreting cells. , 1984, Cellular immunology.

[9]  N. Noro,et al.  Murine IgA binding factors produced by Fc alpha R(+) T cells: role of Fc gamma R(+) cells for the induction of Fc alpha R and formation of IgA-binding factor in Con A-activated cells. , 1984, Journal of immunology.

[10]  F. Davey,et al.  Lymphocyte response to pokeweed mitogen in chronic lymphocytic leukemia , 1984, Cancer.

[11]  N. Kay,et al.  Defective expression of T cell antigens in chronic lymphocytic leukaemia: relationship to T cell dysfunction , 1984, British journal of haematology.

[12]  R. Lynch,et al.  Isotype-specific suppression of IgA: suppression of IgA responses in BALB/c mice by T alpha cells. , 1983, Journal of immunology.

[13]  B. Clarkson,et al.  Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: an analysis by monoclonal antibodies. , 1982, Journal of immunology.

[14]  K. Foon,et al.  Surface markers on leukemia and lymphoma cells: recent advances. , 1982, Blood.

[15]  R. Lynch,et al.  Immunoregulation of murine myeloma in vitro. II. Suppression of MOPC- 315 immunoglobulin secretion and synthesis by idiotype-specific suppressor T cells , 1982, The Journal of experimental medicine.

[16]  B. Dieckgraefe,et al.  T cells with Fc receptors for IgA: induction of T alpha cells in vivo and in vitro by purified IgA. , 1981, Journal of immunology.

[17]  T. Kishimoto,et al.  T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. , 1981, Journal of immunology.

[18]  R. Good,et al.  Subpopulations of Human T Lymphocytes: Laboratory and Clinical Studies , 1981, Immunological reviews.

[19]  G. Canonica,et al.  Receptors for Immunoglobulins on Resting and Activated Human T Cells , 1981, Immunological reviews.

[20]  C. Rabourdin-Combe,et al.  Characterization and Function of T Cell Fcγ Receptor , 1981, Immunological reviews.

[21]  N. Kay,et al.  Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia , 1981, International journal of cancer.

[22]  N. Kay,et al.  Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation. , 1981, Blood.

[23]  P. Nowell,et al.  Proliferation, differentiation, and cytogenetics of chronic leukemic B lymphocytes cultured with mitomycin-treated normal cells , 1981 .

[24]  F. Davey,et al.  T-lymphocyte function in B-cell chronic lymphocytic leukemia. , 1980, Clinical immunology and immunopathology.

[25]  B. Clarkson,et al.  Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: augmentation by in vitro treatment with interferon. , 1980, Journal of immunology.

[26]  T. Kishimoto,et al.  In vitro induction of IgM secretion and switching to IgG production in human B leukemic cells with the help of T cells. , 1980, Journal of immunology.

[27]  P. Hersey,et al.  Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia. , 1980, Clinical and experimental immunology.

[28]  H. Kunkel,et al.  Differentiation Capacity and Other Properties of the Leukemic Cells of Chronic Lymphocytic Leukemia * , 1979, Immunological reviews.

[29]  A. Gottlieb,et al.  Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens. , 1979, The Journal of clinical investigation.

[30]  L. Moretta,et al.  Human T Cell Subpopulations in Normal and Pathologic Conditions , 1979 .

[31]  C. Rabourdin-Combe,et al.  T-cell hybrids bear Fcγ receptors and secrete suppressor immunoglobulin binding factor , 1979, Nature.

[32]  J. Decker,et al.  A receptor for IgA on human T lymphocytes. , 1979, Journal of immunology.

[33]  R. Lynch,et al.  Antigen-specific regulation of myeloma cell differentiation in vivo by carrier-specific T cell factors and macrophages. , 1978, Journal of immunology.

[34]  J. Smith,et al.  Immunologic studies in chronic lymphocytic leukemia: defective stimulation of T-cell proliferation in autologous mixed lymphocyte culture. , 1977, Journal of the National Cancer Institute.

[35]  W. Fridman,et al.  Suppression of in vitro antibody synthesis by immunoglobulin-binding factor , 1975, The Journal of experimental medicine.

[36]  E. Cronkite,et al.  Clinical staging of chronic lymphocytic leukemia. , 1975, Blood.

[37]  H. Eisen,et al.  Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune system. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Katz.  The IgE antibody system is coordinately regulated by FcR epsilon-positive lymphoid cells and IgE-selective soluble factors. , 1985, International archives of allergy and applied immunology.

[39]  K. Ishizaka.  Regulation of IgE synthesis. , 1984, Annual review of immunology.

[40]  D. Lio,et al.  Enumeration of TG lymphocytes in B-chronic lymphocytic leukaemia (B-CLL) by a rapid double-rosetting technique. , 1984, Diagnostic immunology.

[41]  A. Abbas,et al.  Immunologic regulation of lymphoid tumor cells: model systems for lymphocyte function. , 1982, Advances in immunology.

[42]  A. Bøyum,et al.  Separation of leukocytes from blood and bone marrow. Introduction. , 1968 .

[43]  R. Schwartz,et al.  Autoimmune hemolytic anemia: clinical correlations and biological implications. , 1966, Seminars in hematology.